Trial · NCT03809429
Outcomes27
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
21 to 27 of 27
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| SECONDARY | Ongoing Pregnancy Rate | 10-11 weeks after transfer (up to approximately 4 months after start of stimulation) | Participants analyzed for this endpoint represent participants who were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Ongoing Implantation Rate | 10-11 weeks after transfer (up to approximately 4 months after start of stimulation) | Participants analyzed for this endpoint represent participants who were evaluable for this outcome measure. | Embryos | NUMBER |
| SECONDARY | Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) | Up to 9 days after triggering of final follicular maturation | Participants analyzed for this endpoint represent participants who were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Proportion of Subjects With Late OHSS (Including OHSS of Moderate/Severe Grade) | >9 days after triggering of final follicular maturation | Participants analyzed for this endpoint represent participants who were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Frequency of Adverse Events | From time of signing informed consent until the end-of-trial (approximately 7 months) | Participants analyzed for this endpoint represent participants who were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Intensity of Adverse Events | From time of signing informed consent until the end-of-trial (approximately 7 months) | Participants analyzed for this endpoint represent participants who were evaluable for this outcome measure. | Percentage of participants | NUMBER |
| SECONDARY | Technical Malfunctions of the Pre-filled Injection Pen | Up to 20 days | Participants analyzed for this endpoint represent participants who were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03809429/outcomes?page=2